Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The financial performance shows mixed results: a decrease in total investment income and book value, but a positive outlook with reduced expenses and increased loan portfolio yield. Asset sales and diversification efforts are promising, yet nonaccruals and vague management responses raise concerns. The dividend guidance and shareholder return plans are positive, but the lack of clear guidance on asset monetization and market strategy adds uncertainty. Considering the market cap, the stock price is likely to remain stable, resulting in a neutral sentiment.
Adjusted Net Investment Income $0.32 per share, covering the $0.32 per share dividend paid in cash on March 31. Supported by consistent recurring income from the loan portfolio and a full voluntary incentive fee waiver of $6.1 million.
Portfolio Sale Approximately $470 million of illiquid and hard-to-value positions sold at 94% of December 31 book value. This liquidity was used to deleverage the balance sheet and buy high-quality assets at less than 94 cents on the dollar.
Stock Buybacks $57 million completed by March 31, with an additional $9 million executed post-March, leaving $30 million remaining in the original program. Book value per share increased to $10.95 pro forma for post-March buybacks.
Book Value Per Share $10.92 as of March 31, down $0.23 from Q4 pro forma $11.15. Decline driven by broader market bearishness and credit-specific movements.
Nonaccruals at Fair Value 2.6% for the quarter, a modest increase from last quarter. New additions include Affordable Care and Convey, with expectations for Affordable Care to come off nonaccrual in the coming quarters.
Total Investment Income $69 million for the quarter, an 11% decrease compared to the prior quarter. Driven by strong core income and incentive fee waiver.
Net Expenses $37 million for the quarter, an 18% decrease versus the prior quarter, inclusive of the fee waiver.
Loan Portfolio Yield Increased to 11.1% during the quarter due to higher yields on originations and the higher-for-longer shift in the forward curve.
Net Debt-to-Equity Ratio 1.08:1 as of March 31, within the target range of 1x to 1.25x.
Recurring Investment Income 98% of total investment income in the first quarter, with 83% paid in cash.
Market Disruption Investments: NMFC has been leveraging market disruptions to buy high-quality assets at significant discounts, such as acquiring a loan from a multibillion-dollar public company at 65 cents on the dollar, which later appreciated by 10 points.
AI Integration in Portfolio Companies: NMFC's software companies are implementing AI to enhance workflows and improve software functionality, positioning them to benefit from AI advancements.
Private Credit Market Trends: Despite media scrutiny, NMFC sees no systemic credit stress in the private credit market and highlights its defensive growth strategy in sectors like healthcare and IT infrastructure.
Portfolio Sale and Deleveraging: NMFC sold $470 million of illiquid positions at 94% of book value, using the proceeds to deleverage its balance sheet and invest in higher-quality assets.
Share Buyback Program: NMFC repurchased $66 million worth of shares at a 27% discount to book value, with $80 million remaining in buyback authorization.
Dividend Coverage and Yield: NMFC declared a $0.25 dividend for Q2 2026, fully covered by net investment income, with a dividend yield of approximately 12% annualized.
Interest Rate Management: NMFC has shifted its liability mix to 73% floating rate, aligning with its 89% floating rate loan portfolio to mitigate interest rate risks.
Strategic Portfolio Shift: NMFC reduced exposure to software and increased portfolio diversity, focusing on defensive growth sectors.
Equity Monetization Plans: NMFC plans to monetize equity positions in the near to medium term, aiming to redeploy proceeds into cash-yielding loans.
Operational Improvements in Nonaccruals: NMFC is working on improving challenged companies like Affordable Care and Convey, expecting positive outcomes in the near term.
CFO Departure: The CFO, Kris Corbett, is leaving the company at the end of May, which could create temporary disruptions in financial management and strategic planning until a permanent successor is found.
Portfolio Sale Impact: The sale of $470 million of illiquid and hard-to-value positions at 94% of book value could lead to potential risks if the reinvested assets do not perform as expected or if market conditions worsen.
Nonaccrual Loans: Nonaccruals at fair value increased to 2.6%, with specific challenges in Affordable Care and Convey, which could impact financial performance if recovery efforts are not successful.
Market Valuation Decline: Broader market bearishness has led to a $0.23 decline in book value per share, primarily driven by market movements rather than specific loan performance, which could affect investor confidence.
Software Sector Exposure: The company has moderated its software exposure, but the sector remains under scrutiny due to potential risks associated with AI and market volatility.
Credit-Specific Challenges: Certain portfolio companies, such as Affordable Care and Convey, are undergoing restructuring and operational challenges, which could delay recovery and impact returns.
Interest Rate Sensitivity: The company’s earnings could face pressure in scenarios where base rates decrease, despite efforts to align floating rate liabilities with floating rate assets.
Private Credit Market Risks: Increased scrutiny of the private credit market and potential systemic credit stress could impact the company’s portfolio performance and investor sentiment.
Dividend Guidance: A $0.25 dividend is payable on June 30 to shareholders of record as of June 16, and it is expected to be covered by earnings from the core business.
Share Buyback Program: The Board has authorized an incremental $50 million for share buybacks, bringing the total remaining capacity to approximately $80 million. Each $10 million of buyback at $8 per share is expected to add approximately $0.04 per share of book value.
Market Conditions and Investment Strategy: The company is leveraging market disruptions to buy high-quality assets at significant discounts and deploying cash into new loans at higher yields compared to 12 months ago. Spreads in the market have widened, creating opportunities for attractive investments.
Portfolio Performance and Recovery: Forward momentum is observed in companies from past defaults, with plans to sell these companies above current marks and redeploy proceeds into attractive alternatives. Specific examples include Benevis, UniTek, and Permian.
AI and Software Sector Outlook: The company believes its software investments are well-positioned to benefit from AI integration, enhancing margins and operational efficiency. AI is expected to improve software functionality and user experience.
Equity Monetization and M&A Outlook: The company plans to monetize equity winners in the near to medium term, contingent on strong portfolio performance and an improving M&A marketplace. Redeploying equity proceeds into cash-yielding loans is expected to enhance earnings power.
Credit Performance and Nonaccruals: The company expects Affordable Care to exit nonaccrual status in the coming quarters following a restructuring process. Convey is also expected to recover strongly under new leadership.
Interest Rate Sensitivity: The company has shifted its liability mix to nearly match the percentage of floating-rate liabilities with floating-rate assets, mitigating earnings pressure in scenarios of decreasing base rates.
Market Trends and Private Credit: The company remains optimistic about the private credit asset class, citing attractive risk-adjusted returns and enhanced yields. New deal activity is picking up, and spreads have widened, offering compelling credit opportunities.
Dividend Payment for Q1 2026: Adjusted net investment income for the first quarter was $0.32 per share, covering the $0.32 per share dividend paid in cash on March 31.
Dividend Payment for Q2 2026: A $0.25 dividend is payable on June 30 to shareholders of record as of June 16. This dividend is expected to be covered by earnings from the core business.
Dividend Program Overview: Since its IPO in 2011, NMFC has returned over $1.5 billion to shareholders through its dividend program, generating an annualized return of approximately 10%. The current dividend yield is approximately 12% annualized based on the revised $0.25 quarterly payout.
Share Buyback Program for 2025: A $95 million buyback authorization was in place at year-end 2025. By March 31, 2026, $57 million of buybacks were completed, with an additional $9 million executed since, leaving $30 million remaining in the original program.
Incremental Share Buyback Authorization: The Board authorized an additional $50 million for future buybacks, bringing the total remaining capacity to approximately $80 million.
Impact of Share Buybacks on Book Value: Every $10 million of buyback at $8 per share adds approximately $0.04 per share of book value. The pro forma book value per share increased from $10.92 to $10.95 due to post-March buybacks.
The financial performance shows mixed results: a decrease in total investment income and book value, but a positive outlook with reduced expenses and increased loan portfolio yield. Asset sales and diversification efforts are promising, yet nonaccruals and vague management responses raise concerns. The dividend guidance and shareholder return plans are positive, but the lack of clear guidance on asset monetization and market strategy adds uncertainty. Considering the market cap, the stock price is likely to remain stable, resulting in a neutral sentiment.
The earnings call presents a mixed sentiment. Positive aspects include consistent dividend coverage, strategic asset sales, and a strong loan portfolio rating. However, the decline in NAV and total investment income, along with the lack of strong growth indicators, balance out the positives. The Q&A session reassures investors about strategic asset sales and leverage management. Considering the company's market cap, a neutral stock price movement is expected, with no strong catalysts for significant change in either direction.
The earnings call presented a mixed picture: strong shareholder returns through dividends and buybacks, but a decline in NAV and total investment income. The Q&A highlighted potential risks, such as nonaccruals and challenges in key investments like Beauty Supply and Edmentum. The approval of a new buyback program and strategic refinancing plans are positive, but uncertainties in portfolio sales and management's vague responses limit confidence. Given the company's small-cap status, the stock is likely to remain neutral, with fluctuations possible as more details emerge.
The earnings call presents mixed signals. While the dividend protection program and stock repurchase are positives, revenue and NAV declines, along with industry-specific challenges, dampen sentiment. The Q&A reveals management's optimism about future stability, but uncertainties in tariff impacts and portfolio optimization remain. Considering the market cap, a neutral stock price movement is expected.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.